1 year 2.41
Extreme 2.41
3.72
3 years 0.47
Extreme 0.4701
20.4
5 years 0.47
Extreme 0.4701
273.6
10 years 0.47
Extreme 0.4701
363.2
Manager TitleAgeSince
Chief Executive Officer 63 23/03/2025
Chief Tech/Sci/R&D Officer - 01/09/2024
Chief Tech/Sci/R&D Officer 48 01/01/2007
Director TitleAgeSince
Chairman 52 01/01/2006
Director/Board Member 57 28/10/2024
Director/Board Member 61 28/10/2024
Date Insider Type Main position Quantity % Market Cap. Importance
8/20/25 A Tax

Chief Executive Officer

5,232 0.0206%
6/9/25 A Conversion

Founder

4,931,692 25.0063%
5/20/25 A Tax

Chief Executive Officer

5,073 0.0257%
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-.--% - - 96.4M
-2.46%+4.61%+5.01%+114.28% 106B
+3.10%-7.09%+6.60%+17.97% 104B
-14.59%-25.01%+56.52%+620.81% 52.43B
+1.44%-1.66%-2.59%+85.19% 32.79B
+0.90%+1.43%+48.63%+74.94% 29.5B
+0.35%+1.51%+44.82%+90.93% 28.03B
-1.09%+3.69%+38.76%+418.82% 22.8B
+1.12%-2.57%-19.18%-16.36% 20.12B
-0.26%-1.91%-6.33%+28.12% 16.86B
Average -1.43%-2.57%+19.14%+159.41% 45.84B
Weighted average by Cap. -1.52%-3.41%+17.40%+154.59%
Logo Chrome Holding Co.
Chrome Holding Co., formerly 23andMe Holding Co., is a genetics-led consumer healthcare company. As a part of TTAM Research Institute (TTAM), the Company operates and provides customers with personalized deoxyribonucleic acid (DNA) testing and research services.
Employees
261
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
MarketScreener Ratings - Chrome Holding Co.